Analysis of prognosis of patients who were treated with oral immunotherapy.

Analysis of prognosis of patients who were treated with oral immunotherapy. - Prognosis after completing oral immunotherapy.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000018179

Enrollment

500

Registered

2015-08-16

Start date

2015-08-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Food Allergy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who had received oral immunotherapy for an allergy to egg, cow's milk, wheat or peanut, and had been judged to be tolerant more than one year.

Exclusion criteria

Exclusion criteria: Patients who did not agree to participate in the study.

Design outcomes

Primary

Measure	Time frame
Rate of patients who experienced allergic reactions after completing oral immunotherapy.	—

Secondary

Measure	Time frame
1.Rate of patients who used adrenaline self-injector. 2.Consumption frequency of tolerated foods. 3.Consumption of tolerated foods with or without reluctance. 4.Consumption of tolerated foods and allergic reactions experienced at school.	—

Countries

Japan

Contacts

Public ContactSakura Sato

National Hospital Organization Sagamihara National Hospital Department of Allergy, Clinical Research Center for Allergy and Rheumatology

s-sato@sagamihara-hosp.gr.jp042-742-8311

Outcome results